Rising Estimates Add No New Information to CLS WAIT Thesis

What happened

Zacks published a positive article on Celestica, noting that earnings estimates are improving due to AI infrastructure demand, new hyperscaler programs, and strong cash flow. This sentiment aligns with the company's Q1 2026 results, which showed 53% revenue growth and raised full-year guidance. However, the DeepValue master report already incorporates these positive developments and maintains a WAIT rating due to valuation and execution risks. The article does not provide new operational data addressing key risks such as customer concentration (top customer at 35% of revenue) and the $1B capex ramp. Investors should treat this as a reflection of existing optimism rather than a change in fundamentals.

Implication

The improving earnings estimates confirm the AI infrastructure demand story and could limit downside in the short term. Yet, the stock trades at 43x earnings, embedding expectations for flawless execution of the capacity ramp and stable margins. Key risks include a single customer comprising 35% of revenue and potential delays from power/grid constraints, which could pressure utilization and margins. Until the company proves it can sustain CCS margins near 8.5% and normalize working capital, the risk of a sharp drawdown remains. A better risk-adjusted entry would be closer to $300, with a trim level above $420.

Thesis delta

The news item is consistent with the bull scenario but does not change the WAIT rating. It highlights positive sentiment but omits the operational risks detailed in the master report. No shift in conviction or valuation target.